Repros Therapeutics - Ownership and Business Overview

Life ScienceCompany

Repros Therapeutics Ownership

Who owns Repros Therapeutics?

Repros Therapeutics is owned by Allergan. It was acquired on December 12, 2017.

Repros Therapeutics Business Overview

Where is Repros Therapeutics headquartered?

Repros Therapeutics is headquartered in The Woodlands, Texas.

How many employees does Repros Therapeutics have?

Repros Therapeutics has 26 employees.

What sector is Repros Therapeutics in?

Repros Therapeutics is a life science company.

When was Repros Therapeutics founded?

Repros Therapeutics was founded in 1987.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Repros Therapeutics, Inc.

2408 Timberloch Place, B-7,
The Woodlands, Texas 77380
United States,
(281) 719-3400
www.reprosrx.com

Repros Therapeutics, Inc. is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. Repros Therapeutics was founded in 1987 and is based in The Woodlands, Texas.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.